Paul Tudor Jones Dynavax Technologies Corp Transaction History

Tudor Investment Corp Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $1.18 Million - $1.88 Million	-89,609 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $820,818 - $1.78 Million	89,609 New	89,609 $1.72 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $169,521 - $254,508	-45,448 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $196,335 - $531,741	45,448 New	45,448 $196,000
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $150,470 - $204,392	-10,271 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $177,688 - $247,325	10,271	10,271 $192,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.